Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

A3 ME3034 SPECIALTIES > W01 - PSYCH: Anxiety Disorders; Psychopharmacology > Flashcards

W01 - PSYCH: Anxiety Disorders; Psychopharmacology Flashcards

(50 cards)

Start Studying
1
Q

To define the symptoms of anxiety disorders.

A

brought on by perception of a threat that may or may not be present

Psychological arousal

Autonomic Arousal

Muscle Tension

Hyperventilation

Sleep Disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anxiety Disorders

A
  • particular stimulants or generalised anxiety
  • F>M, but cultural and alcohol factors

Phobic Disorders

Anxiety Disorders

Obsessive Compulsive Disorders

PTSD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phobic Disorders

A

Core symptoms of GAD but specific and particular stimuli

  • phobic avoidance
  • Sufferer also experiences anxiety if there is a perceived threat of encountering the feared object or situation “anticipatory anxiety”

*Phobic
* Social = tremor and blushing pre-dominant
* Agoraphobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anxiety Disorders

A

+ Fear-related disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

OCD

A

intrusive, egodistonic (unwanted and unpleasant)
= result in compulsion = physical action or mental effort as a result of the obsession

*M=F
* aetiology = 5HT receptor and functionning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PTSD

A

associated with stress
*F>M (USA)
* Vulnerability factors; genetic susceptibility

*delayed/protracted reaction to stressor or exceptional severity

*Hyperarousal

Re-experiencing phenomena

Avoidance of reminders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mgmt of Phobic Disorders

A

Social Phobia mgmt
> Cognitive Behavioural Therapy

> Education and advice

> Medication SSRI antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mgmt of OCD

A

> education and planning; involving close contacts

> Serotonergic: SSRI Fluoxetine,
Clomipramine

> CBT: exposure and response prevention, examination and weakening convictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mgmt of PTSD

A

> screening of survivors at 1mos

> watchful waiting, review
trauma-focussed CBT
eye movement desensitisation reprocessing
sedatives (risk of dependence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Models of Stress

A

Balance between processing perceived threat and perceived ability to cope

= problem focussed coping

= emotion focussed coping

*yerkes dodson curve = bell curve of stressXperformance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DDx of Anxiety Disorders

A

1) Psychiatric Conditions
Depression
Schizophrenia
Dementia
Substance Misuse

2) Physical Conditions
Thyrotoxicosis
Phaeochromoctoma
Hypoglycaemia
Asthma and or Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Generalised Anxiety Disorder

A

“In general terms GAD for instance is caused by a stressor acting on a personality predisposed to the disorder by a combination of genetic factors and environmental influences in childhood.”

  • pretty common, F>M
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mgmt of GAD

A

> Counselling
Clear Plan of Management
Explanation and education
Advice re caffeine, alcohol, exercise etc.

> Relaxation training
Group or individual
DVDs, tapes or clinician led

Medication
!Sedatives have high risk dependency
>Antidepressants SSRI or TCA

> Cognitive Behavioural Therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mgmt with Antidepressants

A
  • selection based on response hx, sfx, coexisting conditions
  • 2-4w delay before improvement

indications: uni/bipolar, organic, anxiety: OCD, social, PTSD

Medication
(1) SSRI

(2) SNRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SSRIs

A

tx for anxiety and depressive symptoms
serotinergic

sfx: GI upset, sexual dysf., anxiety, restlessness, nervousness, insomnia, fatigue/sedation, dizziness

little cardiotox in overdose

  • discontinuation syndrome = agitation, GI uspset, disequilibrium, dysphoria

> FLUOXETINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Activation syndrome and deactivation syndrome

A

activation = ⇧serotonin = GI, anxiety, panic and agitation
2-10d; warn pt.!

discontinuation = agitation, GI uspset, disequilibrium, dysphoria
* more common w/ shorter half life drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Fluoxetine

A

*SSRI

  • long half-life thus ⇩discontinuation syndrome; but can build up
  • initially activating thus good for energy levels
  • good for pt with noncompliance issues
  • inapp for hepatic pt.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sertaline

A

*SSRI

  • weak P450 = good inpolypharmacy
  • short half life = low build up risk
  • less sedating
  • full stomach req for max absorption
  • GI adverse reaction risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TCAs

A
  • effective family but significant sfx profile

antihistaminic, cholinergic, adrenergic
lethal overdose
Long QT syndrome

  • secondary TCA metabolites, sfx less severe as 3º TCA
  • tertiary TCAs cross-react w/ other receptors = more sfx

> Amitriptyline
Desipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MAOIs

A
  • irreversibe binding and increase of NE, dop, serotonin
  • indicated in resistant depresseion

*SFX: ortho hypoT, wt gain, dry mouth, sedation, sexual dysf., sleep disturbance

!cheese reaction = tyramine-rich foods precipitate hypertensive crisis
- cheese
-cured meats
- pickled fermented foods
- high salt sauces
- alcoholic beverages

!serotonin syndrome: ⇧serotonin = GI, tachy, hyperpyrexia
- 2w break before switching to MAOI from SSRI except for fluoxetine = 5w break dt long half life

> Selegiline
Isocarboxazid
Phenelzine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

SNRIs

Study These Flashcards
A
  • inhibit serotonin and NA uptake like TCA but without poor sfx profile
  • depression, anxiety, NEUROPATHIC PAIN

> Venlafexine
Duloxetine

22
Q

Venlafexine

Study These Flashcards
A

*SNRI

*minimal drug interactions
*short half-life = fast renal clearance thus good for renal pt and geris

  • increase in diastolic BP
  • GI sfx
  • bad discontinuation syndrome thus TAPER
    *QT
  • sexual dysf.
23
Q

Duloxetine

Study These Flashcards
A
  • SNRI
  • beneficial for physical symptoms for depression
  • less BP sfx than venlafexine
  • drug-interactions
  • bad LT compliance
24
Q

Vortioxetine

Study These Flashcards
A
  • SNRI
  • less GI sfx, BP sfx

*expensive!!!

25
Mirtazapine
* novel antidepress. * serotinergic, may augment SSRI + hypnotic at lower doses 2º to antihistaminic effects * !increases cholesterol, wt gain * very sedating
26
Tx-Resistant Depression
> SSRI / SNRI + Mirtazepine +Lithium + or antipsychotic > ECT
27
Prophylactic Tx of Depression
1st episode = requires 6mos post remission 2nd episode = requires 1yr post remission 3rd epiisode = lifelong *risks of relapse
28
Indications of mood stabilisers
bipolar, cyclothymia, schizoaffective *lithium * anticonvulsants * antipsych.
29
Lithium
* reduces suicide rate * LT prophylaxis in mana and depressive episodes * +ve outcome = +ve FH response, pure mania (Bip. I), mania followed by depp. ! UE & TSH monitoring = steady state after 5d. then 3mos check, and then 6mos = goal between 0.6-1.2
30
Lithium Sfx
GI, diarrhea * thyroid abn = polyuria/dypsia * leukocytosis * hair loss, acne * reduced seizure threshold, cognitive slowing !lithium toxicity!
31
Valproic acid
* effective in mania, not as. much in deppr; better tolerated than lithium * pt +ve. predictors - rapid cycliing - comorbd substance issues - comorbid anxiety disorders * baseline liver function tests, prego, FBC !folic acid reduction = neral tube defect
32
valproic acid sfx
platelet dysfunction GI sfx wt gain sedation, tremor hair loss *LFT increase, but not of concern unless triples+
33
Why avoid valproic acid in child bearing women
Risk of neural tube defect secondary to folic acid reduction
34
Acute mania mgmt
> olanzapine quetiapine risperidone. If you're taking an antidepressant when the mania or hypomania starts, your doctor or nurse may advise you to stop taking the antidepressant. !agranulocytosis; +mood stab: lithium + or mood stab: Na valporate (CI in young child bearing) Carbamezepine = acute mania and mania prophylaxis - basline liver function tests, FBC, ECG - follow up and adjust at 1mos * for rapid cyclers and mixed patients
35
Carbamezepine sfx
Rash most common GI sfx sedation, dizzy AV conduction delays D-D interactions
36
Lamotrigine
* anticonvulsants and neuropathic pain with baselines * if stopped for 5d must restart initiation dose pattern
37
Lamotrigine sfx
GI sfx sedation, dizzy *toxic epidermal necrolysis * SJS *blood dyscrasias *d-d= and valproic acid, sertaline can increase lamotrigine levels
38
Antipsychotics
for: schizophrenia, schizoaffective, bipolar, or when augementing agent in resistant disorders * dopamine receptor antagonists (1) high risk to extrapyramidal sfx= high binding (2) high cardiotox. and ACh sfx = low binding dt receptor cross-interaction (3) atypical serotonin-dop. antag. = 1 > Fluphenazine > Haloperidol > Pimozide 2 > risperidone > chlorpromazine > Thioridazine 3
39
What is the most significant projections in the brain concerned in psychoticsymptoms and patients
mesocortical
40
What is the most significant projections in the brain concerned in positive symptoms (hallucinations and dleusions etc.) in patients
mesolimbic
41
Risperidone
* atypical but acts like a typical at higher doses * increased extrapyramidal sfx * most. likely to induce hyperprolactinemia * best profile for existing hyperlipidemia * wt gain and sedation * ci: hypotension, extrapyramidal akathisia
42
Olanzapine
* atypical antipsychotic * hypercholesterolemia + etc., +wt gain * hyperprolactinemia risk * abn LFTs
43
Quetiapine
* atypical antipsych * most likely to cause orthostatic hypotension * abn LFT * wt gain, but lesser risk * hypercholesterolemia etc
44
Aripiprazole
* atypical antipsyc *1st line? *partial D2 agonist * nil wt gain, QT prolong, low sedation * but significant D-D interactions thus dosing required in polypharm.
45
Clozapine
* reserved for treatment resistant but very effective despite sfx profile * agranulocytosis = thus persistent monitoring * increased risk of seizures * !sedation, wt gain, abn LFTs, hypercholesterolemia etc
46
Significance of insight and link to relapse
Commonest psychotic symptom is lack of insight = greatest reason for non-compliance = relapse * third episode = reduced functionning, lower IQ, negative symptoms
47
Most significant antipsychotic adverse effects
tarditive dyskinesia = involuntary muscle movements, may not resolve with cessation *neuroleptic malignant syndrome = PSYCHIATRIC EMERGENCY, muscle. rigidity, fever,mental status, autonomic instability, deragend bloods *extrapyramidal side effects:acute dystonia, parkinson syndrome, akathisia
48
mgmt of extrapyramidal syndrome
> anticholinergics: benztropine etc. > dopamine facilitators: amantadine > betablockers (akathisia) >benzodiazepines (akathisia) !ACh d-d interactions
49
Significance of akathisia
increased risk for suicide! >BB > benzodiazepines
50
Anxiolytics
* used in tandem with SSRIs/SNRIs in GAD > Buspirone - serotonin agonist, nil sedation, 2w acting > benzodiazapines - insomnia in anxiety disorders, used in withdrawal but significant sfx profile

A3 ME3034 SPECIALTIES (27 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions